• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化感染中铜绿假单胞菌的抗生素耐药性患病率:一项系统评价和荟萃分析。

Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysis.

作者信息

Bonyadi Parisa, Saleh Narjes Tehrani, Dehghani Mohadeseh, Yamini Mahsa, Amini Kumarss

机构信息

Department of Microbiology, College of Bioscience, Arak Islamic Azad University, Arak, Iran.

Department of Biomedical, Center Tehran Branch, Islamic Azad University, Tehran, Iran.

出版信息

Microb Pathog. 2022 Apr;165:105461. doi: 10.1016/j.micpath.2022.105461. Epub 2022 Feb 28.

DOI:10.1016/j.micpath.2022.105461
PMID:35240288
Abstract

OBJECTIVE

Pseudomonas aeruginosa is an opportunistic pathogen that infects the lungs of people with cystic fibrosis (CF) and is the most common cause of chronic respiratory infections with high morbidity and mortality in CF patients. This study aimed to evaluate the pattern of antibiotic resistance of P. aeruginosa strains from patients with CF using a systematic review and meta-analysis.

METHODS

A comprehensive and systematic search was performed for relevant articles until August 2021 in the following database: PubMed, Scopus, Embase, and Web of Science. Finally, 122 articles with appropriate criteria were included in the meta-analysis. To estimate weighted pooled proportions Freeman-Tukey double arcsine transformation was performed using Metaprop command in Stata software version 17.1.

RESULTS

122 studies evaluated the pattern of P. aeruginosa antibiotic resistance from different antibiotic classes in patients with CF. Cefotaxime had the highest resistance rate of 67% (95% CI 53_80%), while colistin had the lowest 5% (95% CI 2-8%).

CONCLUSION

High resistance to most of the studied antibiotics was observed. The high antibiotic resistance observed is worrying and it indicates the need to monitor using of antibiotics. In addition, colistin is the most appropriate treatment choice, but more randomized controlled trial studies are recommended.

摘要

目的

铜绿假单胞菌是一种机会致病菌,可感染囊性纤维化(CF)患者的肺部,是CF患者慢性呼吸道感染最常见的病因,发病率和死亡率很高。本研究旨在通过系统评价和荟萃分析评估CF患者中铜绿假单胞菌菌株的抗生素耐药模式。

方法

截至2021年8月,在以下数据库中对相关文章进行了全面系统的检索:PubMed、Scopus、Embase和Web of Science。最后,122篇符合适当标准的文章被纳入荟萃分析。为了估计加权合并比例,使用Stata软件17.1版中的Metaprop命令进行Freeman-Tukey双反正弦变换。

结果

122项研究评估了CF患者中不同抗生素类别铜绿假单胞菌的抗生素耐药模式。头孢噻肟的耐药率最高,为67%(95%可信区间53_80%),而黏菌素最低,为5%(95%可信区间2-8%)。

结论

观察到对大多数研究抗生素的高耐药性。观察到的高抗生素耐药性令人担忧,这表明需要监测抗生素的使用。此外,黏菌素是最合适的治疗选择,但建议进行更多随机对照试验研究。

相似文献

1
Prevalence of antibiotic resistance of Pseudomonas aeruginosa in cystic fibrosis infection: A systematic review and meta-analysis.囊性纤维化感染中铜绿假单胞菌的抗生素耐药性患病率:一项系统评价和荟萃分析。
Microb Pathog. 2022 Apr;165:105461. doi: 10.1016/j.micpath.2022.105461. Epub 2022 Feb 28.
2
Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.吸入性抗假单胞菌抗生素用于囊性纤维化的长期治疗。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD001021. doi: 10.1002/14651858.CD001021.pub4.
3
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004197. doi: 10.1002/14651858.CD004197.pub2.
4
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2018 Sep 17;9(9):CD009530. doi: 10.1002/14651858.CD009530.pub4.
5
Macrolide antibiotics for cystic fibrosis.用于囊性纤维化的大环内酯类抗生素。
Cochrane Database Syst Rev. 2004(2):CD002203. doi: 10.1002/14651858.CD002203.pub2.
6
Nebulised anti-pseudomonal antibiotics for cystic fibrosis.用于囊性纤维化的雾化抗假单胞菌抗生素
Cochrane Database Syst Rev. 2003(3):CD001021. doi: 10.1002/14651858.CD001021.
7
Nebulised anti-pseudomonal antibiotics for cystic fibrosis.用于囊性纤维化的雾化抗假单胞菌抗生素
Cochrane Database Syst Rev. 2000(2):CD001021. doi: 10.1002/14651858.CD001021.
8
Oral anti-pseudomonal antibiotics for cystic fibrosis.用于囊性纤维化的口服抗假单胞菌抗生素。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD005405. doi: 10.1002/14651858.CD005405.pub2.
9
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.根除囊性纤维化患者体内耐甲氧西林金黄色葡萄球菌(MRSA)的干预措施。
Cochrane Database Syst Rev. 2018 Jul 21;7(7):CD009650. doi: 10.1002/14651858.CD009650.pub4.
10
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.针对囊性纤维化患者中耐甲氧西林金黄色葡萄球菌(MRSA)的清除干预措施。
Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD009650. doi: 10.1002/14651858.CD009650.pub5.

引用本文的文献

1
Emergence of extensively and pan-drug resistance in clinical bacterial isolates: A systematic scoping review from Ethiopian public health perspective.临床细菌分离株中广泛耐药和泛耐药的出现:从埃塞俄比亚公共卫生角度进行的系统综述。
PLoS Negl Trop Dis. 2025 Aug 28;19(8):e0013363. doi: 10.1371/journal.pntd.0013363. eCollection 2025 Aug.
2
Let-7b-5p loaded Mesenchymal Stromal Cell Extracellular Vesicles reduce -biofilm formation and inflammation in CF Bronchial Epithelial Cells.负载Let-7b-5p的间充质基质细胞外囊泡可减少囊性纤维化支气管上皮细胞中的生物膜形成和炎症。
bioRxiv. 2025 May 28:2025.05.28.656674. doi: 10.1101/2025.05.28.656674.
3
Overcoming in Chronic Suppurative Lung Disease: Prevalence, Treatment Challenges, and the Promise of Bacteriophage Therapy.
慢性化脓性肺病的攻克:患病率、治疗挑战及噬菌体疗法的前景
Antibiotics (Basel). 2025 Apr 23;14(5):427. doi: 10.3390/antibiotics14050427.
4
Zinc sulfate acts as an efflux pump inhibitor on Pseudomonas aeruginosa clinical isolates.硫酸锌对铜绿假单胞菌临床分离株起外排泵抑制剂的作用。
World J Microbiol Biotechnol. 2025 Apr 28;41(5):139. doi: 10.1007/s11274-025-04352-4.
5
Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon.揭示巴西亚马逊地区囊性纤维化患者肺部感染中铜绿假单胞菌的分子流行病学。
BMC Microbiol. 2025 Apr 9;25(1):203. doi: 10.1186/s12866-025-03920-w.
6
Reduced prevalence of phage defense systems in strains from cystic fibrosis patients.囊性纤维化患者菌株中噬菌体防御系统的流行率降低。
mBio. 2025 Apr 9;16(4):e0354824. doi: 10.1128/mbio.03548-24. Epub 2025 Feb 25.
7
High-risk clones harboring β-lactamases: 2024 update.携带β-内酰胺酶的高危克隆:2024年更新
Heliyon. 2024 Dec 26;11(1):e41540. doi: 10.1016/j.heliyon.2024.e41540. eCollection 2025 Jan 15.
8
Phage therapy to treat cystic fibrosis complex lung infections: perspectives and challenges.噬菌体疗法治疗囊性纤维化复杂肺部感染:前景与挑战
Front Microbiol. 2024 Oct 18;15:1476041. doi: 10.3389/fmicb.2024.1476041. eCollection 2024.
9
Prevalence of colistin resistance in clinical isolates of : a systematic review and meta-analysis.临床分离株中黏菌素耐药性的流行情况:一项系统评价和荟萃分析。
Front Microbiol. 2024 Oct 9;15:1477836. doi: 10.3389/fmicb.2024.1477836. eCollection 2024.
10
Multi-year comparison of VITEK MS performance for identification of rarely encountered pathogenic Gram-negative organisms (GNOs) in a large integrated Canadian healthcare region.在加拿大一个大型综合医疗保健区域中,对VITEK MS鉴定罕见致病性革兰氏阴性菌(GNOs)的性能进行多年比较。
Microbiol Spectr. 2024 Oct 22;12(12):e0227624. doi: 10.1128/spectrum.02276-24.